The relationship between diet and brain health has been studied for decades through the lens of individual nutrients, omega-3 fatty acids, antioxidants, B vitamins, and their respective contributions to cognitive function and neurological disease risk. A newer and more powerful research framework has emerged over the past eight years that looks not at individual nutrients but at the degree of industrial processing that food has undergone before it reaches the plate. The ultra-processed food (UPF) category, defined by the NOVA classification system developed by Carlos Monteiro at the University of São Paulo, includes foods that contain ingredients not found in home kitchens, including emulsifiers, flavor enhancers, colorants, humectants, and artificial preservatives, and that are manufactured through industrial processes including extrusion, molding, and pre-frying that fundamentally alter the food matrix. The research connecting this category of food to cognitive decline has accelerated significantly since 2022, and the findings are consistent enough across multiple large datasets and study designs to warrant serious attention from anyone who eats, which is to say everyone.

What the NOVA Classification System Is and Why It Matters

The NOVA system classifies foods into four groups based on the extent and purpose of industrial processing rather than on nutrient content. Group 1 includes unprocessed and minimally processed foods including fresh vegetables, fruit, meat, fish, eggs, and plain yogurt. Group 2 includes processed culinary ingredients including oils, butter, flour, and sugar used in cooking. Group 3 includes processed foods made by adding salt, sugar, or oil to Group 1 foods, including canned vegetables, cheese, and cured meats. Group 4, the ultra-processed category, includes products manufactured from substances extracted from foods or synthesized from other organic compounds, combined with additives designed to make them hyper-palatable, visually appealing, and shelf-stable.

The cognitive health research has focused almost exclusively on Group 4 foods because the epidemiological associations with adverse health outcomes are strongest and most consistent in this category, and because the biological mechanisms connecting ultra-processed food specifically to disease risk are becoming increasingly well-characterized. The UPF category includes the foods that dominate the modern Western diet: packaged bread, breakfast cereals, reconstituted meat products, flavored yogurts, soft drinks, packaged snacks, instant noodles, and most fast food items.

The Cognitive Decline Evidence

The most cited study connecting ultra-processed food to cognitive decline was published in JAMA Neurology in 2022 by Natalia Gonçalves and colleagues, drawing on data from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil), which followed over 10,000 civil servants aged 35 to 74 across an eight-year period. Participants in the highest quartile of UPF consumption, consuming more than 20 percent of their daily calories from ultra-processed foods, showed a 28 percent faster rate of global cognitive decline and a 25 percent faster rate of executive function decline compared to the lowest quartile, after adjusting for total caloric intake, socioeconomic status, education, physical activity, smoking, and depression.

The executive function finding is particularly clinically significant because executive function, the cognitive domain that governs planning, decision-making, impulse control, and cognitive flexibility, is one of the earliest domains affected in the prodromal stages of Alzheimer’s disease and other dementias, and its decline in middle-aged adults is a recognized risk marker for later dementia development. The ELSA-Brasil participants showing accelerated executive function decline were not elderly. The mean age at baseline was approximately 51 years, placing the cognitive effects of ultra-processed food consumption in middle age rather than late life.

A subsequent study published in The Lancet Regional Health using data from the UK Biobank, which followed over 72,000 adults across a mean follow-up of nine years, found that each 10 percent increase in the proportion of calories consumed from ultra-processed foods was associated with a 25 percent higher risk of developing dementia, a 14 percent higher risk of Alzheimer’s disease specifically, and a 28 percent higher risk of vascular dementia. The associations were dose-dependent, meaning higher UPF consumption was associated with proportionally higher risk across the full range of intake rather than only at extreme levels, suggesting a continuous biological relationship rather than a threshold effect.

The Biological Mechanisms

Several biological mechanisms have been proposed and partially characterized to explain the cognitive effects of ultra-processed food, and they are not mutually exclusive. The most evidence-supported involve neuroinflammation, the gut-brain axis, cardiovascular pathology, and the displacement of neuroprotective nutrients.

Neuroinflammation is the mechanism with the most direct biological plausibility. Ultra-processed foods consistently elevate circulating levels of pro-inflammatory cytokines including interleukin-6 and C-reactive protein in human feeding studies, and neuroinflammation is now recognized as a central pathological driver of Alzheimer’s disease, Parkinson’s disease, and vascular dementia. Research published in Nature Aging found that microglial activation, the brain-resident immune cell response that mediates neuroinflammation, was significantly elevated in people with higher dietary inflammatory index scores, and that sustained microglial activation produces the synaptic pruning and amyloid plaque accumulation that characterize Alzheimer’s pathology.

The gut-brain axis provides a second mechanistic pathway. Ultra-processed foods are low in dietary fiber and high in emulsifiers including carboxymethylcellulose and polysorbate-80, compounds that research published in Nature found disrupted the intestinal mucus layer and altered gut microbiome composition in animal models, producing systemic inflammation and metabolic endotoxemia. The gut microbiome produces neurotransmitter precursors including tryptophan, the serotonin precursor, and short-chain fatty acids that regulate neuroinflammation and support blood-brain barrier integrity. A dysbiotic microbiome driven by ultra-processed food consumption disrupts all of these neuroprotective functions simultaneously.

Cardiovascular pathology contributes to cognitive decline through multiple overlapping mechanisms including reduced cerebral blood flow, cerebral small vessel disease, and the accumulation of white matter hyperintensities that impair neural connectivity. Ultra-processed foods elevate cardiovascular risk through their effects on blood pressure, lipid profiles, insulin resistance, and arterial stiffness, and each of these cardiovascular risk factors independently increases dementia risk through its effects on cerebrovascular health. Research published in Stroke found that dietary patterns high in ultra-processed foods were associated with significantly higher rates of cerebral small vessel disease on MRI compared to whole food dietary patterns, even after controlling for traditional cardiovascular risk factors.

Nutrient displacement is the final mechanism and the most practically important from a dietary intervention standpoint. Ultra-processed foods occupy caloric space in the diet that would otherwise be occupied by foods containing the nutrients most strongly associated with cognitive protection, including omega-3 fatty acids, B vitamins, polyphenols, and dietary fiber. A diet providing 50 percent of calories from ultra-processed foods is, almost by definition, a diet deficient in the neuroprotective nutrients that population studies consistently associate with lower dementia risk, regardless of whether the ultra-processed foods contain any individually harmful ingredients.

What the Research Does Not Yet Establish

The cognitive decline research is compelling but not without limitations that are worth stating clearly rather than glossing over. The majority of the epidemiological evidence is observational, meaning it documents associations between ultra-processed food consumption and cognitive outcomes without establishing causation through experimental manipulation. Residual confounding, the possibility that UPF consumption is a marker of broader lifestyle and socioeconomic patterns that are the true drivers of cognitive risk, cannot be entirely excluded despite the extensive adjustment for confounders in the better studies.

Randomized controlled trials testing the cognitive effects of reducing UPF consumption are methodologically challenging and expensive to conduct over the timescales relevant to cognitive outcomes, which measure in years to decades rather than weeks. The SMILES trial, published in BMC Medicine, found that a dietary intervention reducing ultra-processed food intake and increasing whole food consumption produced significant improvements in depression scores over twelve weeks compared to a social support control, demonstrating that measurable neurological effects of dietary change are detectable within clinically practical timeframes, though cognitive rather than mood outcomes require longer follow-up to assess.

The Practical Implication

The practical implication of the research is not that occasional consumption of ultra-processed food produces meaningful cognitive harm. The epidemiological associations are driven by habitual patterns in which UPF constitutes a large proportion of total caloric intake over years and decades. The relevant question for most people is not whether to eliminate UPF entirely but whether UPF currently occupies enough of their diet to warrant a meaningful reduction.

Research published in BMJ Open found that ultra-processed foods account for approximately 57 percent of caloric intake in the average American adult diet and approximately 64 percent in adolescents, suggesting that meaningful reduction is possible for most people without approaching elimination. Replacing one UPF-dominated meal per day with a whole food alternative reduces UPF exposure by approximately 30 percent for an average consumer, a change that is both practically achievable and, based on the dose-dependent nature of the associations, likely to produce a proportional reduction in the biological risk the research documents.

The GLP-1 diet approach shift covered in the broader piece on how GLP-1 medications are changing nutritional thinking intersects with the ultra-processed food research in an important way. One of the most consistently observed effects of GLP-1 receptor agonists is a reduction in the preference for the hyper-palatable, calorie-dense ultra-processed foods that the medications’ effects on dopamine reward circuitry specifically dampen, suggesting that pharmacological intervention may partially address the neurobiological drivers of ultra-processed food overconsumption that dietary willpower alone has proven insufficient to overcome for a significant proportion of the population.